Phase II Study of Pembrolizumab and Fractionated External Beam Radiotherapy in Patients With Relapsed and Refractory Non-Hodgkin Lymphoma
Phase of Trial: Phase II
Latest Information Update: 06 Aug 2018
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Diffuse large B cell lymphoma; Follicular lymphoma; Non-Hodgkin's lymphoma; T cell lymphoma
- Focus Therapeutic Use
- 01 Nov 2017 Planned End Date changed from 1 Apr 2021 to 1 Nov 2020.
- 01 Nov 2017 Planned primary completion date changed from 1 Apr 2021 to 1 Nov 2020.
- 01 Nov 2017 Status changed from not yet recruiting to recruiting.